Stop Smoking Or Heart Problems? Pfizer, FDA Discussing Chantix Issues
Pfizer's stop-smoking drug Chantix (varenicline) can lead to a small increase in cardiovascular problems such as heart attacks for patients who already have cardiovascular disease, U.S. drug regulators said on Thursday. In fact, The Food and Drug Administration (FDA) is changing the label for Chantix after reviewing the results of a clinical trial. Annual sales are now about $800 million, making ...

FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
SILVER SPRING, Md., June 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment.

Are Two FDA Approvals in One Week a Positive Sign?
Don't count on it.